Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- FPMAJ to Propose System That May Raise NHI Prices of Existing Drugs: Mr Nagano
September 4, 2006
- DSP, Sumitomo Chemical Agree with Pfizer on Settlement of Amlodin Lawsuit
September 4, 2006
- BUSINESS NEWS IN BRIEF
September 4, 2006
- NEW PRODUCTS
September 4, 2006
- BUSINESS NEWS IN BRIEF
August 28, 2006
- NEW PRODUCTS
August 28, 2006
- COMMENTARY／Korosho Gets Involved to Eliminate Provisional Delivery
August 28, 2006
- Drug Development Beyond Borders -Today's Global Cooperative Clinical Trials-
August 28, 2006
- Drug Firms Should Support Job Sharing between Regional Med. Institutions: Mr Matsubara
August 28, 2006
- Use of Generic Drugs Increasing at Tokyo Municipal Hospitals
August 28, 2006
- Drug Makers Actively Outsourcing to India: MediBic
August 28, 2006
- Doctors Object to Generics Use Promotion Service
August 28, 2006
- STOP PRESS／Schering-Plough Withdraws NDA for Garenoxacin It Submitted to FDA
August 28, 2006
- GENERIC NEWS IN BRIEF
August 28, 2006
- Wholesalers Express Opposition to Annual NHI Price Revision
August 28, 2006
- Once-Yearly NHI Price Revisions Too Costly: FJPWA's President Matsutani
August 28, 2006
- Discussions on Healthcare Reform Should Focus on Public Interest: Mr Urushibata of NPhA
August 28, 2006
- REGULATORY NEWS IN BRIEF
August 28, 2006
- SELF-MEDICATION NEWS IN BRIEF
August 28, 2006
- Olympus Acquires Bacus to Provide Advanced Virtual Slide System
August 28, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…